0001140361-21-027415.txt : 20210806 0001140361-21-027415.hdr.sgml : 20210806 20210806200034 ACCESSION NUMBER: 0001140361-21-027415 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210804 FILED AS OF DATE: 20210806 DATE AS OF CHANGE: 20210806 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kennedy Brendan CENTRAL INDEX KEY: 0001746070 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38594 FILM NUMBER: 211154316 MAIL ADDRESS: STREET 1: 1920 EASTLAKE AVENUE E. CITY: SEATTLE STATE: WA ZIP: 98105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tilray, Inc. CENTRAL INDEX KEY: 0001731348 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 824310622 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 519.322.8800 MAIL ADDRESS: STREET 1: 655 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 4 1 form4.xml FORM 4 X0306 4 2021-08-04 0001731348 Tilray, Inc. TLRY 0001746070 Kennedy Brendan C/O TILRAY, INC. 655 MADISON AVENUE, 19TH FLOOR NEW YORK NY 10065 true Class 2 Common Stock 2021-08-04 4 S 0 300000 14.0809 D 8274196 D Class 2 Common Stock 2021-08-05 4 S 0 300000 14.4619 D 7974196 D Class 2 Common Stock 234940 I By: Skyline & Mayfair LLC The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.89 to $14.54, inclusive. The reporting person undertakes to provide to Tilray, Inc., any security holder of Tilray, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.89 to $14.74, inclusive. The reporting person undertakes to provide to Tilray, Inc., any security holder of Tilray, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3). The reporting person is the sole member of Skyline & Mayfair LLC and has sole voting and investment power with respect to the shares held by Skyline & Mayfair LLC. /s/ Carl A. Merton, as attorney-in-fact for Brendan Kennedy 2021-08-06